The Namita Thapar-backed Emcure Pharma IPO has opened for subscription with a price band of Rs 594-600 per share. The IPO has received a strong response from investors, with the grey market premium (GMP) currently at Rs 200-220. Investors are advised to carefully consider their options before deciding whether to apply for this IPO.
Source link
BJP to use oppn's own words to foil attack over Dhankhar exit
As opposition parties prepare to use Jagdeep Dhankhar's unexpected resignation to criticize the government, the ruling party plans to highlight previous criticisms from the opposition, which accused the former Vice President of bias and acting as a government spokesperson. This political maneuvering underscores the ongoing tensions and strategic positioning between the two sides. Want More Context? 🔎
Read more